Over the last 25 years, (ED) medications such as Viagra and others have become common and normal pieces of bedroom tool kit.

OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other disorders, the companies said on Monday.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

There are plenty of reasons to consider coming off the pill, from wanting to conceive to trying to get back in touch with your regular rhythms. But beware the people online who demonise hormonal ...

In the arena of outdoor speakers, few models come close to the might of the JBL Charge 5. The Award-winning Charge 5 is even more durable and hardwearing than the four Charges that came before it, and ...

Different types of birth control pills are available, including low-dose, extended-cycle, and conventional pills. It’s important to talk with a doctor to understand the benefits and risks and ...

Actor Gene Hackman was likely dead for 10 days before he and his wife’s body were discovered at their Santa Fe, N.M., home earlier this week. The Oscar winner and his wife were found dead with ...

Manufacturers of penis enlargement pills claim these pills can enlarge ... smaller than average may actually have an average penis size. A 2021 study notes that many men think that the average ...

Abortion pill maker enters legal battle over FDA rules by Alejandra O’Connell-Domenech - 02/26/25 2:47 PM ET by Alejandra O’Connell-Domenech - 02/26/25 2:47 PM ET ...

If passed, the EPIC Act would remove the so-called “pill penalty,” which poses a strong disincentive against developing small-molecule drugs, Thomas Kaiser, co-founder and chief scientific officer at ...

By Lisa Lerer The country’s largest manufacturer of abortion pills is wading into the first major legal battle over abortion of President Trump’s second term. The company, GenBioPro ...

The Inflation Reduction Act targets small molecules for government price setting years earlier than other medicines, sending the wrong message to everyone trying to develop new breakthrough treatments ...